Logo image
Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor Tetra-O-methyl-NDGA
Journal article   Peer reviewed

Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor Tetra-O-methyl-NDGA

Hongshan Chen, Li Teng, Jian-Nong Li, Richard Park, David E. Mold, John Gnabre, Jih Ru Hwu, Wen Nan Tseng and Ru Chih C. Huang
Journal of Medicinal Chemistry, Vol.41(16), pp.3001-3007
30/07/1998

Abstract

We had previously reported that tetramethyl-O-NGDA (M <sub>4</sub> N), a synthetic derivative of the naturally occurring nordihydroguaiaretic acid (NDGA), is able to inhibit HIV Tat transactivation by blocking host Sp1 protein at the Sp1 cognate binding site on the HIV LTR promoter. The present studies were undertaken to examine whether M <sub>4</sub> N is able to inhibit the replication of herpes simplex virus (HSV), another Sp1-regulated virus. The results showed that in Vero cells, M <sub>4</sub> N inhibits at micromolar levels (IC <sub>50</sub> = 43.5 μM) the expression of the herpes immediate early gene (α-ICP4), which is essential for HSV replication. An electrophoretic mobility shift assay, examining Sp1 binding to the α-ICP4 promoter, showed a significant inhibition of the control bands: 88% inhibition of the fast moving band (FMB) and 45% of the slow moving band (SMB), at 100 μM of drug concentration. Comparative studies between M <sub>4</sub> N and acycloguanosine (acyclovir, ACV) in cultured Vero cells revealed an interesting pattern in the drug sensitivity (IC <sub>50</sub> ) and cytotoxicity (TC <sub>50</sub> ) parameters. For M <sub>4</sub> N, the IC <sub>50</sub> varied between 11.7 and 4 μM in 10 passages of HSV-1 and 4 passages of HSV-2 with no indication for a requirement of higher drug concentration. In contrast, for acyclovir, the IC <sub>50</sub> increased from 7 μM in the first passage to 444 μM in the tenth passage of HSV-1, and >88 μM for the fourth passage of HSV- 2, indicating a rapid build-up of drug resistance against acyclovir. While the selective index (SI), defined as the ratio: TC <sub>50</sub> /IC <sub>50</sub> , remained relatively constant for M <sub>4</sub> N; it dropped 60-fold for acyclovir in the endpoints of viral passages. Drug sensitivity for M <sub>4</sub> N toward the acyclovir- sensitive strain (sm44) and the acyclovir-resistant strain (ACV-10) of HSV-1 was similar, indicating no cross-resistance between M <sub>4</sub> N and acyclovir in their anti-HSV effects. These results may have an important clinical relevance since HSV has been shown to be a factor for spreading of HIV.

Details

Logo image